Berwing K, Friedl A, Schaper J, Huth C, Schwarz T, Klövekorn W P, Schlepper M
Kardiologische Abteilung, Kerckhoff-Klinik GmbH, Bad Nauheim.
Z Kardiol. 1994 Mar;83(3):225-33.
Due to the invasive nature of myocardial biopsies, a complication rate of up to 2.5%, and the limitations, e.g., at focal distribution of rejection, there is a continuous need for reliable, non-invasive parameters in recognizing moderate (grade 2) and severe (grade 3) acute cardiac allograft rejections in patients treated with cyclosporine A. 64 biopsies of 20 patients with previous heart transplantations in the past 3 weeks to 36 months (mean 11 months) were compared prospectively to Doppler and echocardiographic results. Parameters of systolic function such as percent fractional shortening (FS) and systolic wall thickness of the posterior wall (SWT) remained without significant changes at grade 2 and grade 3 rejections. The same is valid for relaxation parameters such as maximum velocity of posterior wall reduction (PTR), the time interval of endsystole to maximum velocity of posterior wall reduction (tES-PTR), and the isovolumic relaxation time (IVRT). Left-ventricular filling parameters such as maximum early diastolic flow velocity (VEmax) increased significantly from 73.3 +/- 15.2 cm/s in the rejection-free interval (grade 0) to 103.9 +/- 15.0 cm/s at grade 2 rejection and 101.1 +/- 9.2 cm/s at grade 3 rejection (both p < 0.001). A sensitivity of 50% and a negative predictive value of 77% are, however, too low to diagnose or exclude a moderate or severe acute rejection in the individual case.(ABSTRACT TRUNCATED AT 250 WORDS)
由于心肌活检具有侵入性、并发症发生率高达2.5%以及存在局限性(如排斥反应呈局灶性分布),因此一直需要可靠的非侵入性参数来识别接受环孢素A治疗的患者中中度(2级)和重度(3级)急性心脏移植排斥反应。对20例在过去3周至36个月(平均11个月)内接受过心脏移植的患者的64次活检进行了前瞻性研究,并与多普勒和超声心动图结果进行比较。在2级和3级排斥反应时,收缩功能参数如缩短分数百分比(FS)和后壁收缩期壁厚(SWT)没有显著变化。舒张参数如后壁最大下降速度(PTR)、收缩末期至后壁最大下降速度的时间间隔(tES - PTR)和等容舒张时间(IVRT)也是如此。左心室充盈参数如舒张早期最大流速(VEmax)在无排斥反应期(0级)为73.3±15.2 cm/s,在2级排斥反应时显著增加至103.9±15.0 cm/s,在3级排斥反应时为101.1±9.2 cm/s(均p<0.001)。然而,50%的敏感性和77%的阴性预测值过低,无法在个体病例中诊断或排除中度或重度急性排斥反应。(摘要截短至250字)